Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the Phase I part of this research study is to determine the safest and most
effective dose of Abraxane when given in combination with carboplatin and Erbitux during
radiation therapy for head and neck cancer. The purpose of the Phase II part of this study is
to determine the effects of the treatment on head and neck cancers, as well as to further
study the safety of this treatment.